Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma

BACKGROUND: Vascular endothelial growth factor (VEGF) plays an important role in the growth and metastatic progression of melanoma. Exposure of melanoma cells to chemotherapy induces VEGF overproduction, which in turn may allow melanoma cells to evade cell death and become chemotherapy resistant. Th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer 2009-01, Vol.115 (1), p.119-127
Hauptverfasser:	Perez, Domingo G., Suman, Vera J., Fitch, Tom R., Amatruda, Thomas, Morton, Roscoe F., Jilani, Shamim Z., Constantinou, Costas L., Egner, James R., Kottschade, Lisa A., Markovic, Svetomir N.
Format:	Artikel
Sprache:	eng
Schlagworte:	angiogenesis chemotherapy metastatic melanoma phase 2 trials
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!